Norges Bank Acquires New Holdings in HCA Healthcare, Inc. $HCA

Norges Bank bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,008,113 shares of the company’s stock, valued at approximately $1,152,408,000. Norges Bank owned about 1.29% of HCA Healthcare as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. ORG Partners LLC boosted its stake in shares of HCA Healthcare by 27.9% during the second quarter. ORG Partners LLC now owns 142 shares of the company’s stock valued at $55,000 after purchasing an additional 31 shares in the last quarter. Glenview Trust co grew its holdings in HCA Healthcare by 2.3% during the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after acquiring an additional 32 shares during the last quarter. Horizon Investments LLC raised its stake in shares of HCA Healthcare by 1.1% during the first quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after acquiring an additional 33 shares during the last quarter. Sivia Capital Partners LLC grew its stake in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the last quarter. Finally, RWA Wealth Partners LLC raised its position in HCA Healthcare by 2.0% during the 1st quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company’s stock worth $658,000 after purchasing an additional 37 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of a number of analyst reports. The Goldman Sachs Group raised their price objective on HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 25th. Bank of America increased their price target on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a report on Monday, October 27th. Finally, Mizuho upped their target price on HCA Healthcare from $475.00 to $505.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $474.53.

HCA Healthcare Price Performance

Shares of HCA opened at $512.94 on Friday. The stock has a 50-day moving average of $452.07 and a 200-day moving average of $406.12. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $520.00. The company has a market cap of $117.05 billion, a PE ratio of 19.83, a P/E/G ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter last year, the firm posted $4.90 earnings per share. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is presently 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.